The clinical survival time of patients with amyotrophic lateral sclerosis is 3-5 years. The disease is common in middle-aged and elderly people, and is characterized by progressive skeletal muscle weakness, atrophy, tremor of muscle bundles, medullary palsy and cone bundle signs. At present, amyotrophic lateral sclerosis is an incurable disease, and the various approaches used clinically can only improve the quality of life of patients. Therefore, early diagnosis and treatment of this disease should be carried out so that the survival of patients can be prolonged as much as possible. Currently, drugs that slow down the progression of the disease, like riluzole, can be used to delay the progression of the patient’s disease very well. However, patients will also experience fatigue and nausea, and their liver function will be damaged to some extent. It is important to manage the patient’s nutrition well and to have a balanced diet. If the patient has difficulty swallowing, a gastrostomy is performed at this time. Sometimes the patient has to be ventilated with a ventilator for respiratory support.